Literature DB >> 2801323

Pharmacological comparison of active and passive experimental allergic encephalomyelitis in the rat.

S Desai1, R Barton.   

Abstract

Models of actively induced and passively transferred experimental allergic encephalomyelitis (EAE) have been compared in the rat. The time of disease onset, severity of clinical symptoms and percent incidence were compared and assessed for their suitability for evaluation of immunosuppressive agents. The passive EAE model had an earlier disease onset (6 +/- 0.1 days) and 100% of the cell recipients (n = 45) developed severe clinical symptoms, including paralysis of the tail and hind limbs. In contrast, the active EAE model had a mean disease onset day of 13 +/- 0.1 and only 53% of the induced rats (n = 85) developed EAE clinical symptoms which were variable. The average symptom score in both models was inhibited by dexamethasone (1 mg/kg/day p.o.; day 0 to 3), methotrexate (3 mg/kg i.p. single dose; day 1) and cyclosporin A (30 mg/kg/day p.o.; day 0 to 7). The above study indicates that the passive EAE model is more advantageous for pharmacologic evaluation of immunosuppressive agents.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2801323     DOI: 10.1007/bf01972820

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A.

Authors:  H S Panitch; D E McFarlin
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

2.  T lymphocyte line-mediated experimental allergic encephalomyelitis--a pharmacologic model for testing of immunosuppressive agents for the treatment of autoimmune central nervous system disease.

Authors:  M E Westarp; H Wekerle; A Ben-Nun; I R Cohen; M L Vohl; H Przuntek
Journal:  J Pharmacol Exp Ther       Date:  1987-08       Impact factor: 4.030

3.  Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing.

Authors:  A Ben-Nun; Y Ron; I R Cohen
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

4.  Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.

Authors:  D J Hinrichs; C M Roberts; F J Waxman
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

5.  The influence of cyclosporin A on the development of actively induced and passively transferred experimental allergic encephalomyelitis.

Authors:  D J Hinrichs; K W Wegmann; B A Peters
Journal:  Cell Immunol       Date:  1983-04-01       Impact factor: 4.868

Review 6.  Autoimmune diseases of myelin.

Authors:  P Y Paterson
Journal:  Prog Clin Biol Res       Date:  1980

7.  Suppression of experimental allergic encephalomyelitis by tilorone: cell transfer and interferon studies.

Authors:  S Levine; R Sowinski; S L Abreu
Journal:  Immunopharmacology       Date:  1983-06
  7 in total
  3 in total

1.  Role of platelet activating factor in the pathogenesis of active and passive models of experimental allergic encephalomyelitis in the rat.

Authors:  S Desai; R Barton
Journal:  Agents Actions       Date:  1990-08

2.  Effect of the leukotriene B4 receptor antagonist, SC-41930, on experimental allergic encephalomyelitis (EAE) in the guinea pig.

Authors:  D J Fretland; D L Widomski; R L Shone; S Levin; T S Gaginella
Journal:  Agents Actions       Date:  1991-09

3.  The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE).

Authors:  C Bolton
Journal:  Agents Actions       Date:  1992-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.